UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
NCT Number: NCT06575348
This study is being done to establish the feasibility of performing a clinical trial using a mHealth application named YouControl-AFib designed to improve the cardiovascular health of persons with atrial fibrillation. The study will obtain feedback on the app design to inform future versions and will collect preliminary data to support proof-of-concept and potential effect sizes for future trial design.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792, United States
Primary Objective
Secondary Objectives
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will use the app for 3 months, includes 1 month phone call with Health Coach
Time frame: up to 5 months
Time frame: up to 5 months
Time frame: 3 months
Mobile App Rating Scale contains several subscales that will each be scored on a scale of 1-5; B-functionality, C-aesthetics, and D-information. Higher scores indicate high levels of functionality, aesthetics, and information quality.
Time frame: baseline, 3 months
Time frame: baseline, 3 months
Time frame: baseline, 3 months
Time frame: baseline, 3 months
SF-12 measures the impact of health on the participant's life and is scored from 0-100 where higher scores indicates higher health related quality of life.
Time frame: baseline, 3 months
PHQ-9 is a 9-item questionnaire scored on a 4 point likert scale from 0-3 for a total possible range of scores from 0-27. Higher scores indicate increased depression.
Time frame: baseline, 3 months
AFEQT is a 20-item survey scored on a 7 point likert scale from 1-7 where higher scores indicate higher effect that atrial fibrillation has on the participant's quality of life.
Time frame: baseline, 3 months
AFSS is a 7-item survey scored on a likert scale from 0-5 for a total possible range of scores from 0-35 where higher scores indicate greater symptom severity.
Time frame: baseline, 3 months
AFKAT is a 21-item true / false assessment that measures knowledge about atrial fibrillation. Correct answers are scored with a 1 for a total possible range of scores from 0-21. Higher scores indicate increased knowledge of atrial fibrillation.
Time frame: baseline, 3 months
Life's Essential 8 score (LE8) is a composite score between 0-100 that assesses a participant's adherence to 8 lifestyle recommendations with improve cardiovascular health: diet, physical activity, smoking habits, body mass index, cholesterol, blood glucose, and sleep duration. Higher scores are indicative of higher adherence to healthy lifestyle.
Time frame: baseline, 3 months
Time frame: baseline, 3 months
Participants will obtain single-lead ECGs at baseline and after three months. The time-voltage data are run through an ECG-AI model for estimating ECG-age. ECG-age is a novel metric developed by investigators at Wake Forest. See reference section for relevant publication describing a similar model. Summary results will be reported as ECG-age in years.
University of Wisconsin, Madison
Other
Implementation of the YouControl-AFib mHealth Application (Pilot Version) to Improve Physical Activity in Persons With Atrial Fibrillation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05085860
Arrhythmias, Cardiac, Atrial Fibrillation
Ottawa, Ontario, Canada
View Trial DetailsNCT03241433
Arrhythmias, Cardiac, Atrial Fibrillation
Minneapolis, Minnesota, United States
View Trial DetailsNCT02493400
Arrhythmias, Cardiac, Atrial Fibrillation
Gothenburg, Sweden
View Trial DetailsNCT01673139
Arrhythmias, Cardiac, Atrial Fibrillation
Trondheim, Norway
View Trial Details